drugset / Trial / NCT01419730

Vitamin D and Physical Activity on Bone Health

NCT01419730

Phase 2 Active not recruiting 191 enrolled University of Rochester
RandomizedFactorialDouble-blindTreatment

Summary

This research will examine the effectiveness of vitamin D or placebo (the placebo is a tablet that looks like Vitamin D study drug, but has no Vitamin D study drug in it), with and without physical activity (walking and progressive resistance exercise), in treating bone loss in women who have undergone treatment for breast cancer. The investigators would also like to find out if the physical activity program improves cardiovascular fitness, energy expenditure, muscular strength, muscle mass, and balance. One hundred five (105) subjects are expected to take part in this study. The investigators don't know if bone loss in breast cancer survivors should be treated differently than bone loss in other women.

Timeline

Start
2011-08
Primary completion
2024-12-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 50000 iu

Indications